Post-surgical Delirium in Patients Undergoing Radical Cystectomy.

Sponsor
University of Alexandria (Other)
Overall Status
Recruiting
CT.gov ID
NCT03806439
Collaborator
(none)
100
1
12.9
7.7

Study Details

Study Description

Brief Summary

Post-surgical delirium in patients undergoing radical cystectomy. Introduction Delirium occurs after major abdominal surgery may reach about 15% of the patients.(1)

Aim The aim of this study is to determine the incidence of delirium after radical cystectomy surgery and the associated risk factors in Alexandria University hospital.

Patients and Methods After approval of local ethical committee and patient consent, the study will be done on patients undergoing radical cystectomy surgery in Alexandria University hospitals from January 5th 2019 till January 4th 2020. The 6-item Cognitive Impairment Test (6CIT) and SPMSQ questionnaire will be used. SPMSQ will be done preoperative and daily for 3 days postoperative, at day 7. Phone call for SPMSQ will be done 3, 6, 9 and 12 months after surgery.

Condition or Disease Intervention/Treatment Phase
  • Other: Radical cystectomy.

Detailed Description

Post-surgical delirium in patients undergoing radical cystectomy. Introduction Delirium occurs after major abdominal surgery may reach about 15% of the patients.(1)

Aim The aim of this study is to determine the incidence of delirium after radical cystectomy surgery and the associated risk factors in Alexandria University hospital.

Patients and Methods After approval of local ethical committee and patient consent, the study will be done on patients undergoing radical cystectomy surgery in Alexandria University hospitals from January 5th 2019 till January 4th 2020. The 6-item Cognitive Impairment Test (6CIT) and SPMSQ questionnaire will be used. SPMSQ will be done preoperative and daily for 3 days postoperative, at day 7. Phone call for SPMSQ will be done 3, 6, 9 and 12 months after surgery.

Results Results will be collected in tables and graphs. Appropriate statistical analysis will be done.

Discussion Results of the study will be discussed compared to other studies.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Post-surgical Delirium in Patients Undergoing Radical Cystectomy.
Actual Study Start Date :
Sep 25, 2021
Anticipated Primary Completion Date :
Sep 24, 2022
Anticipated Study Completion Date :
Oct 24, 2022

Arms and Interventions

Arm Intervention/Treatment
Patients undergoing radical cystectomy.

After approval of local ethical committee and patient consent, the study will be done on patients undergoing radical cystectomy surgery in Alexandria University hospitals from January 5th 2019 till January 4th 2020. The 6-item Cognitive Impairment Test (6CIT) and SPMSQ questionnaire will be used. SPMSQ will be done preoperative and daily for 3 days postoperative, at day 7. Phone call for SPMSQ will be done 3, 6, 9 and 12 months after surgery.

Other: Radical cystectomy.
Adult patients undergoing radical cystectomy.

Outcome Measures

Primary Outcome Measures

  1. Delirium [1 year]

    Post-surgical delirium in patients undergoing radical cystectomy.

Secondary Outcome Measures

  1. Mortality [1 year]

    Mortality in patients undergoing radical cystectomy.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria:Adult patients undergoing radical cystectomy. -

Exclusion Criteria: Patient refusal.

-

Contacts and Locations

Locations

Site City State Country Postal Code
1 Alexandria Faculty of Medicine Alexandria Egypt 21111

Sponsors and Collaborators

  • University of Alexandria

Investigators

  • Principal Investigator: Mohammad Hazem I Ahmad Sabry, MB,ChB MD, Alexandria University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mohammad Hazem I. Ahmad Sabry, Lecturer of Anesthesia, University of Alexandria
ClinicalTrials.gov Identifier:
NCT03806439
Other Study ID Numbers:
  • 16/71(8/2/2017)
First Posted:
Jan 16, 2019
Last Update Posted:
Sep 28, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 28, 2021